Insulin resistance can be assessed by a variety of metrics, such as fasting insulin levels, normoglycemic clamp method, and homeostasis model assessment-IR (HOMA-IR) in vivo [11–13], however, these metrics are not routinely measured in clinical practice, especially in nondiabetic patients. The gene discussed is INS; the disease is Insulin resistance.